PPM1D Mutations Drive Clonal Hematopoiesis in Response to Cytotoxic Chemotherapy

Hsu, Joanne I., Dayaram, Tajhal, Tovy, Ayala, De Braekeleer, Etienne, Jeong, Mira, Wang, Feng, Zhang, Jianhua, Heffernan, Timothy P. +12 more·2018·Cell stem cell

Cited by (426)

Items 201–300 of 426

  1. How I treat refractory/relapsed diffuse large B‐cell lymphomas with CD19 ‐directed chimeric antigen receptor T cells
    Arnon Nagler, Vincenzo Maria Perriello, Lorenza Falini, Brunangelo Falini · 2023 · British Journal of Haematology
  2. Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a
    Maria Chiara Fontana, Jacopo Nanni, Andrea Ghelli Luserna di Rorà, Elisabetta Petracci, Antonella Padella, Martina Ghetti, Anna Ferrari, Giovanni Marconi, Simona Soverini, Ilaria Iacobucci et al. · 2021 · Biomedicines
  3. A 2026 update on myelodysplastic neoplasms: current state, challenges and future directions
    Jan Philipp Bewersdorf, Alain Antoine Mina, Maximilian F. Stahl, Amer Methqal Zeidan · 2026 · Nature Reviews Clinical Oncology
  4. Metal dependent protein phosphatase PPM family in cardiac health and diseases
    Chen Gao, Nancy Cao, Yibin Wang · 2021 · Cellular Signalling
  5. Podophyllotoxin-loaded PEGylated E-selectin peptide conjugate targeted cancer site to enhance tumor inhibition and reduce side effect
    Cen Xiang, Ying Fu, Tiantian Hao, Linlin Wei, Yuning Liu, Zhen‐Chuan Fan, Na Guo, Peng Yu, Yuou Teng · 2023 · European Journal of Medicinal Chemistry
  6. Molecular and clinical aspects relevant for counseling individuals with clonal hematopoiesis of indeterminate potential
    Anna Maria Cacic, Felicitas Isabel Schulz, Ulrich Germing, Sascha Dietrich, Norbert Gattermann · 2023 · Frontiers in Oncology
  7. Novel insights and therapeutic approaches in secondary AML
    Giovanni Marconi, Michela Rondoni, Beatrice Anna Zannetti, Irene Zacheo, Davide Nappi, Agnese Mattei, Serena Rocchi, Francesco Lanza · 2024 · Frontiers in Oncology
  8. PPM1D activity promotes cellular transformation by preventing senescence and cell death
    Miroslav Stoyanov, Andra S. Martinikova, Kateřina Matějková, Klára Horáčková, Petra Zemánková, Kamila Burdová, Zuzana Zemanová, Petra Kleiblová, Zdeněk Kleibl, Libor Macůrek · 2024 · Oncogene
  9. Clonal hematopoiesis landscape in frequent blood donors
    Darja Karpova, Hector Huerga Encabo, Elisa Donato, Silvia Calderazzo, Michael Scherer, Miriam Llorian, Aino‐Maija Leppä, Roberto Würth, Patrick Stelmach, Despoina Papazoglou et al. · 2025 · Blood
  10. A novel computational method enables RNA editome profiling during human hematopoiesis from scRNA-seq data
    Yan Wu, Shijie Hao, Xiaojing Xu, Guoyi Dong, Wenjie Ouyang, Chao Liu, Hai‐Xi Sun · 2023 · Scientific Reports
  11. Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy
    Zhuoer Xie, Terra L. Lasho, Arushi Khurana, Alejandro Ferrer, Christy M. Finke, Abhishek Avinash Mangaonkar, Stephen Maxted Ansell, Jenna A. Fernandez, Mithun Vinod Shah, Aref Al‐Kali et al. · 2023 · Haematologica
  12. Low-Frequency PPM1D Gene Mutations Affect Treatment Response to CD19-Targeted CAR T-Cell Therapy in Large B-Cell Lymphoma
    Katja Seipel, Michèle Frey, Henning Nilius, Dilara Akhoundova, Yara Banz, Ulrike Bacher, Thomas Pabst · 2023 · Current Oncology
  13. The Evolving AML Genomic Landscape: Therapeutic Implications
    Sachi Horibata, George Alyateem, Christin B. DeStefano, Michael M. Gottesman · 2020 · Current Cancer Drug Targets
  14. Controversies in the recent (2016) World Health Organization classification of acute myeloid leukemia
    Robert Paul Hasserjian · 2021 · Best Practice & Research Clinical Haematology
  15. PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse
    Adil S. A. Al Hinai, Tim Grob, Melissa Rijken, François G. Kavelaars, Annelieke Zeilemaker, Claudia A. J. Erpelinck-Verschueren, Mathijs Arnoud Sanders, Bob Löwenberg, Mojca Jongen‐Lavrencic, Peter J.M. Valk · 2021 · Leukemia
  16. Clonal haematopoiesis of emerging significance
    Danielle E. Hammond, Sanam Loghavi · 2021 · Pathology
  17. Clonal hematopoiesis and myeloid malignancies: clonal dynamics and clinical implications
    Chiara Elena, Anna Gallì, Elisa B. Bono, Gabriele Todisco, Luca Malcovati · 2021 · Current Opinion in Hematology
  18. Clonal Hematopoiesis: Confluence of Malignant and Nonmalignant Diseases
    Amy Erica Lin, Philipp J. Rauch, Siddhartha Jaiswal, Benjamin L. Ebert · 2022 · Annual Review of Cancer Biology
  19. Advances in understanding the molecular basis of clonal hematopoiesis
    David A. Alagpulinsa, Mabel P. Toribio, Iad Alhallak, Robert J. Shmookler Reis · 2022 · Trends in Molecular Medicine
  20. Somatic mosaic truncating mutations of PPM1D in blood can result from expansion of a mutant clone under selective pressure of chemotherapy
    Borahm Kim, Dongju Won, Seung‐Tae Lee, Jong Rak Choi · 2019 · PLoS ONE
  21. Clonal hematopoiesis and bone marrow inflammation
    Xinshu Xie, Meng Su, Kehan Ren, Xuezhen Ma, Zhiyi Lv, Zhaofeng Li, Yang Mei, Peng Ji · 2022 · Translational research
  22. Clonal Hematopoiesis in Patients With Human Immunodeficiency Virus and Cancer
    Nancy Gillis, Brittney L. Dickey, Christelle Colin, Yi-Han Tang, Ryan M. Putney, Tania Mesa, Sean Yoder, Gita Suneja, Adam M. Spivak, Ami B. Patel et al. · 2024 · The Journal of Infectious Diseases
  23. The emerging role of clonal haematopoiesis in the pathogenesis of dilated cardiomyopathy
    Job A.J. Verdonschot, José J. Fuster, Kenneth Walsh, Stephane R B Heymans · 2024 · European Heart Journal
  24. Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood
    Art Schuermans, Tetsushi Nakao, Yunfeng Ruan, Satoshi Koyama, Zhi Yu, Md Mesbah Uddin, Sara Haidermota, Whitney Hornsby, Adam J. Lewandowski, Alexander G. Bick et al. · 2023 · Journal of the American Heart Association
  25. Pilot Study of Donor-Engrafted Clonal Hematopoiesis Evolution and Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation Recipients Using a National Registry
    Nancy Gillis, Eric Padron, Tao Wang, Karen S. Chen, Jakob D. DeVos, Stephen R. Spellman, Stephanie Joi Lee, Carrie Lynn Kitko, Margaret L. MacMillan, Jeffrey West et al. · 2023 · Transplantation and Cellular Therapy
  26. Stem cell damage after chemotherapy- can we do better?
    Joy Tang, Nan Zhu, Sridhar Rao, Karen-Sue Carlson · 2019 · Best Practice & Research Clinical Haematology
  27. The emerging importance and evolving understanding of clonal hematopoiesis in multiple myeloma
    Christin B. DeStefano, Steven J. Gibson, Adam Samuel Sperling, Paul Gerard Guy Richardson, Irene M. Ghobrial, Clifton Craig Mo · 2022 · Seminars in Oncology
  28. Liquid biopsy for children with central nervous system tumours: Clinical integration and technical considerations
    Reda Stankunaite, Lynley V. Marshall, Fernando Carceller, Louis Chesler, Michael J.F. Hubank, Sally L. George · 2022 · Frontiers in Pediatrics
  29. Germline polymorphisms and the risk of therapy-related myeloid neoplasms
    Koichi Takahashi · 2019 · Best Practice & Research Clinical Haematology
  30. The evolutionary dynamics and fitness landscape of clonal haematopoiesis
    Caroline J. Watson, Alana Papula, Yeuk P. G. Poon, Winghing Wong, Andrew L. Young, Todd E. Druley, Daniel S. Fisher, Jamie R. Blundell · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  31. Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study
    Yael N. Kusne, Terra L. Lasho, Christy M. Finke, Zaid Elsabbagh, Shaylene A. McCue, Timothy J. Hobday, Jason Scott Starr, Tanios Bekaii‐Saab, Thorvardur Ragnar Halfdanarson, Mrinal M. Patnaik et al. · 2024 · JCO Precision Oncology
  32. Decoding Clonal Hematopoiesis: Emerging Themes and Novel Mechanistic Insights
    Shalmali Pendse, Dirk Loeffler · 2024 · Cancers
  33. Future directions in myelodysplastic syndromes/neoplasms and acute myeloid leukaemia classification: from blast counts to biology
    Matteo Giovanni Della Porta, Jan Philipp Bewersdorf, Yu‐Hung Wang, Robert Paul Hasserjian · 2024 · Histopathology
  34. Spectrum, prevalence, and clinical correlates of PPM1D mutations in patients with clonal hematopoiesis and clonal cytopenias
    Talha Badar, Ludovica Marando, Eric Latorre Crespo, Terra L. Lasho, Francyess Denis Oliva, Chenyu Lin, Benjamin J. McCormick, Mobachir El Kettani, Kashish J. Shah, Yael N. Kusne et al. · 2026 · Blood Advances
  35. Big data and single‐cell sequencing in acute myeloid leukemia research
    Yuxuan Zou, Huiyuan Zhang, Hongbo Hu · 2023 · MedComm – Oncology
  36. A blueprint for pursuing therapeutic interventions and early phase clinical trials in clonal haematopoiesis
    Tamanna Haque, Aditi Shastri, Pinkal M. Desai, Zhuoer Xie, Danielle E. Hammond, Zoe King, Ashwin Kishtagari, Yazan F. Madanat, Yasmin Abaza, Alexander James Silver et al. · 2024 · British Journal of Haematology
  37. Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment
    Jichun Chen, Katie A. Matatall, Xingmin Feng, Daniel Hormaechea‐Agulla, Mukesh Maharjan, Neal S. Young, Katherine Y. King · 2020 · Experimental Hematology
  38. A high prevalence of myeloid malignancies in progeria with Werner syndrome is associated with p53 insufficiency
    Hisaya Kato, Yoshiro Maezawa, Dai Nishijima, Eisuke Iwamoto, June Takeda, Takashi Kanamori, Masaya Yamaga, Tatsuzo Mishina, Yusuke Takeda, Shintaro Izumi et al. · 2022 · Experimental Hematology
  39. Secondary Acute Myeloid Leukemia: Pathogenesis and Treatment
    Debora Capelli, Diego Menotti, Alessandro Fiorentini, Francesco Saraceni, Attilio Olivieri · 2022 · Exon Publications eBooks
  40. Clonal hematopoiesis, cardiovascular disease and cancer treatment-induced cardiotoxicity
    Nan Zhang, Xu Tian, Dong-Kun Sun, Gary Tse, Bingxin Xie, Zhiqiang Zhao, Tong Liu · 2025 · Seminars in Cancer Biology
  41. Association of clonal hematopoiesis of indeterminate potential with cardiometabolic multimorbidity progression and mortality: a prospective study of UK Biobank
    Chenzhe Zuo, Dihan Fu, Yuanfeng Huang, Jinchen Li, Shujun Yang, Xunjie Cheng, Guogang Zhang, Tianqi Ma, Qunyong Peng, Yu Tan · 2025 · European journal of medical research
  42. Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer
    Kwang Seob Lee, Choong‐kun Lee, Soon Sung Kwon, Woo Sun Kwon, Sejung Park, Seung‐Tae Lee, Jong Rak Choi, Sun Young Rha, Saeam Shin · 2023 · Clinical Chemistry and Laboratory Medicine (CCLM)
  43. Updates in biology, classification, and management of acute myeloid leukemia with antecedent hematologic disorder and therapy related acute myeloid leukemia
    Kanak Parmar, Rupayan Kundu, Abhishek Maiti, Somedeb Ball · 2024 · Leukemia Research
  44. Kmt2c restricts G-CSF-driven HSC mobilization and granulocyte production in a methyltransferase-independent manner
    Helen C. Wang, Ran Chen, Wei Yang, Yanan Li, Rohini Muthukumar, Riddhi M. Patel, Emily B. Casey, Elisabeth Denby, Jeffrey A. Magee · 2024 · Cell Reports
  45. The Role of Somatic Mutations in Ischemic Stroke: CHIP’s Impact on Vascular Health
    Aiman Kinzhebay, Amankeldi A. Salybekov · 2025 · Neurology International
  46. Emerging Role of Acquired Mutations and Clonal Hematopoiesis in Atherosclerosis ― Beyond Conventional Cardiovascular Risk Factors ―
    María A. Zuriaga, José J. Fuster · 2021 · Circulation Journal
  47. Genomic testing in myeloid malignancy
    Roderick Docking, Aly Karsan · 2019 · International Journal of Laboratory Hematology
  48. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci
    Hetty E. Carraway, Thomas LaFramboise · 2020 · Best Practice & Research Clinical Haematology
  49. Tumor protein 53 mutations in acute myeloid leukemia: conventional induction chemotherapy or novel therapeutics
    Hannah H Asghari, Chetasi Talati · 2020 · Current Opinion in Hematology
  50. Clonality in haematopoietic stem cell ageing
    Maria Terradas-Terradas, Neil Robertson, Tamir Chandra, Kristina Kirschner · 2020 · Mechanisms of Ageing and Development
  51. Early cardio-oncology intervention in thoracic radiotherapy: prospective single-arm pilot study
    Samuel C Zhang, Jordan O. Gasho, Celeste Eno, Katrina D. Silos, Felicity J. Pendergast, Wenjuan Zhang, Eric Vail, Mitchell R. Kamrava, Behrooz Hakimian, Amin J. Mirhadi et al. · 2025 · Communications Medicine
  52. Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial
    Giuseppe Schepisi, Milena Urbini, Chiara Casadei, V. Gallà, Sabrina Rossetti, Umberto Basso, Cristian Lolli, Giorgia Gurioli, Elisabetta Petracci, Sabrina Chiara Cecere et al. · 2025 · ESMO Open
  53. Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated Cancers
    Catherine Handy Marshall, Ali T. Arafa, Ellen Jaeger, Stamatina Fragkogianni, Anne Sonnenschein, Elizabeth A. Mauer, Lukasz P. Gondek, Calvin Y. Chao, Jun Luo, Emmanuel S. Antonarakis · 2025 · Cancers
  54. Dynamics of clonal hematopoiesis and cellular responses to stress-induced toxicity in autologous stem cell transplantation
    Catarina M. Stein, Raphael Hablesreiter, Friederike Christen, Pelle Löwe, Coral Fustero Torre, Klara Kopp, Benjamin Nick Locher, Lena Nitsch, Robert Altwasser, Johanna Franziska Kerschbaum et al. · 2025 · Leukemia
  55. Clonal haematopoiesis - a novel entity that modifies pathological processes in elderly
    Ekaterina Belotserkovskaya, Vasily Golotin, Burhan Uyanik, Oleg N. Demidov · 2023 · Cell Death Discovery
  56. Truncated PPM1D Prevents Apoptosis in the Murine Thymus and Promotes Ionizing Radiation-Induced Lymphoma
    Andra S. Martinikova, Monika Burócziová, Miroslav Stoyanov, Libor Macůrek · 2020 · Cells
  57. Clonal hematopoiesis: Molecular basis and clinical relevance
    Hiroyoshi Kunimoto, Hideaki Nakajima · 2020 · Leukemia Research
  58. Frameshift variations in the RHD coding sequence: Molecular mechanisms permitting protein expression
    Willy A. Flegel, Kshitij Srivastava · 2020 · Transfusion
  59. Cell competition in hematopoietic cells: Quality control in homeostasis and its role in leukemia
    Camila V. Ramos, Vera C. Martins · 2021 · Developmental Biology
  60. Co-targeting WIP1 and PARP induces synthetic lethality in hepatocellular carcinoma
    Miaoqin Chen, Weikai Wang, Shiman Hu, Yifan Tong, Yiling Li, Qi Wei, Lei Yu, Liyuan Zhu, Yiran Zhu, Leiming Liu et al. · 2022 · Cell Communication and Signaling
  61. Clonal Hematopoiesis and the Heart: a Toxic Relationship
    Jeffrey Lee Jensen, Saumya Mariam Easaw, Travis Anderson, Yash Varma, Jiandong Zhang, Brian C. Jensen, Catherine Callaghan Coombs · 2023 · Current Oncology Reports
  62. Updates in molecular genetics of therapy-related myeloid neoplasms
    Miguel Dario Cantu · 2023 · Seminars in Diagnostic Pathology
  63. Recipient clonal hematopoiesis in allogeneic bone marrow transplantation for lymphoid malignancies
    Philip Hollingsworth Imus, Sergiu Paşca, Hua‐Ling Tsai, Yosra M. Aljawai, Kenneth R. Cooke, Jeremy D Walston, Christopher D. Gocke, Ravi Varadhan, Richard John Jones, Lukasz P. Gondek · 2024 · Blood Advances
  64. Cooperative progression of colitis and leukemia modulated by clonal hematopoiesis via PTX3/IL-1β pro-inflammatory signaling
    Hang He, Yuchen Wen, Hanzhi Yu, Jingjing Liu, Qingran Huo, Wenyan Jin, Zhiqin Wang, Guohui Du, Jun Du, Huaquan Wang et al. · 2024 · Genes & Diseases
  65. Premalignant Clonal Hematopoietic Proliferations
    Valentina Nardi, Frank C. Kuo, Robert Paul Hasserjian · 2019 · American Journal of Clinical Pathology
  66. The origin of leukemia: Genetic alterations and inflammatory factors in the development of premalignant clonal hematopoiesis
    Daniel Sjövall, Anna Staffas · 2020 · Seminars in Hematology
  67. Exploring the Associations Between Clonal Hematopoiesis of Indeterminate Potential, Myeloid Malignancy, and Atherosclerosis
    Juan Bautista Menendez-Gonzalez, Neil P. Rodrigues · 2022 · Methods in molecular biology
  68. Multi-ancestry genome-wide association meta-analysis of mosaic loss of chromosome Y in the Million Veteran Program identifies 240 novel loci
    Michael Francis, Bryan R. Gorman, Tim B. Bigdeli, Giulio Genovese, Georgios Voloudakis, Jaroslav M. Bendl, Biao Zeng, Sanan Venkatesh, Chris Chatzinakos, Gabriel E. Hoffman et al. · 2024 · medRxiv
  69. TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA
    Ugo Testa, Germana Castelli, Elvira Pelosi · 2023 · Mediterranean Journal of Hematology and Infectious Diseases
  70. Integrating clonal haematopoiesis into geriatric oncology: The ARCH between aging, cardiovascular disease and malignancy
    Nina Rosa Neuendorff, Lukas Peter Frenzel, Florian Leuschner, Carlo Fremd · 2020 · Journal of Geriatric Oncology
  71. Toward a systems-level probing of tumor clonality
    Emanuelle I. Grody, Ajay Abraham, Vipul Shukla, Yogesh Goyal · 2023 · iScience
  72. Clonal hematopoiesis of indeterminate potential: the root cause of, and fertile ground for, hematological malignancies
    Qiqi Zhuang, Shengjie Jin, Wei Wang, Yan Wang, Hongyan Tong, Zuyun Liu, Jie Sun · 2024 · Trends in Molecular Medicine
  73. The Gata1 murine megakaryocyte–erythroid progenitor cells expand robustly and alter differentiation potential
    Eunju Shin, Jong-Gwan Jeong, Hyunmin Chung, Haiyoung Jung, Charny Park, Suk Ran Yoon, Tae‐Don Kim, Seung Jin Lee, Inpyo Choi, Ji‐Yoon Noh · 2020 · Biochemical and Biophysical Research Communications
  74. Clonal hematopoiesis of indeterminate potential: clinical relevance of an incidental finding in liquid profiling
    Gregor Hoermann · 2022 · Journal of Laboratory Medicine
  75. The Harmful Consequences of Increased Fitness in Hematopoietic Stem Cells
    Megan E. McNerney, Michelle M. Le Beau · 2018 · Cell stem cell
  76. The Immunological Consequences of Clonal Hematopoiesis in Heart Failure
    Megan A. Evans, Kenneth X. Walsh · 2026 · Immunological Reviews
  77. Clonal Hematopoiesis, a Risk Condition for Developing Myeloid Neoplasia
    Ugo Testa, Germana Castelli, Elvira Pelosi · 2025 · Hemato
  78. Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer
    Ing Soo Tiong, Tamia Nguyen, Chong Chyn Chua, Charis E. Teh, Christine Muttiah, Sarah Ftouni, John Francis Seymour, Daniel H.D. Gray, Andrew Warwick Roberts, Sarah‐Jane Dawson et al. · 2025 · Blood Advances
  79. Clonal hematopoiesis in metastatic urothelial and renal cell carcinoma
    Aslı D. Munzur, Jack V. W. Bacon, Francine Fishbein, Cameron Herberts, Gráinne Donnellan, Cecily Q. Bernales, Karan Parekh, Gillian Rae Vandekerkhove, David Christian Müller, Yi Jou Liao et al. · 2025 · npj Precision Oncology
  80. Analysis of clinical and genomic profiles of therapy-related myeloid neoplasm in Korea
    Jiwon Yun, Hyojin Song, Sung‐Min Kim, Soonok Kim, Seok Ryun Kwon, Young Eun Lee, Dajeong Jeong, Jae Hyeon Park, Sunghoon Kwon, Hongseok Yun et al. · 2023 · Human Genomics
  81. Clonal hematopoiesis of indeterminate potential (CHIP): A potential contributor to lymphoma
    QingQing Luo, Lili Zhou, DaYa Luo, Li Yu · 2024 · Critical Reviews in Oncology/Hematology
  82. Radiotherapeutics, clonal hematopoiesis, and risk of hematologic malignancies: The good, the bad, the ugly
    Catherine Handy Marshall, Emmanuel S. Antonarakis, Mrinal M. Patnaik · 2025 · Blood Reviews
  83. The role of the PPM1D gene in tumor pathogenesis
    Aida S. Kucheryavenko, Елена Андреевна Музыко, Valentina Nikolaevna Perfilova, Kamil’ Daniyalovich Kaplanov, M. Yu. Frolov · 2025 · Biomeditsinskaya Khimiya
  84. Clonal hematopoiesis of indeterminate potential and atrial fibrillation
    Jie Liu, Nan Zhang, Guangshuai Teng, Gary Tse, Jie Bai, Gregory Y.H. Lip, Tong Liu · 2025 · Heart Rhythm
  85. Diagnostic Challenge and Clinical Dilemma: The Long Reach of Clonal Hematopoiesis
    Afaf E.G. Osman, Jay L. Patel · 2021 · Clinical Chemistry
  86. Derivation and Clinical Validation of a Redox-Driven Prognostic Signature for Colorectal Cancer
    Qin Dang, Zaoqu Liu, Shengyun Hu, Zhuang Chen, Lingfang Meng, Junhong Hu, Guixian Wang, Weitang Yuan, Xinwei Han, Lifeng Li et al. · 2021 · Frontiers in Oncology
  87. Clonal hematopoiesis of indeterminate potential in the companion dog
    Kimberley N. Sebastian, Hatice Gülçin Özer, Cory Howard, Laura E. Chadsey, Arletta Lozanski, Tzyy-Jye Doong, Shelley J. Orwick, Gerard Lozanski, Wenjuan Ma, William C. Kisseberth et al. · 2022 · Leukemia
  88. Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation
    Khalil Saleh, Ahmadreza Arbab, David Ghez, Camille Bigenwald, Sophie Cotteret, Christophe Marzac, Florence Pasquier, Sylvain Pilorge, Véronique Saada, Véronique Vergé et al. · 2023 · Immunotherapy
  89. Benzene metabolite hydroquinone enhances self-renewal and proliferation of preleukemic cells through the Ppar-γ pathway
    Yedan Lu, Pinpin Sui, Jinzhe Li, Nan Lian, Jin Zhou, Xiurong Cheng, Qian‐Fei Wang, Caihong Xing, Peiyu Xu · 2023 · Toxicology Letters
  90. Regulators of clonal hematopoiesis and physiological consequences of this condition
    Eunbee Park, Megan A. Evans, Kenneth X. Walsh · 2023 · The Journal of Cardiovascular Aging
  91. Potentiality of Protein phosphatase Mg 2+ /Mn 2+ dependent 1D as a biomarker for predicting prognosis in acute myeloid leukemia patients
    Meijia Yu, Jie Hu, Di He, Qi Chen, Suna Liu, Xiaoling Zhu, Bin Li · 2020 · Journal of Clinical Laboratory Analysis
  92. The long-term effects of chemotherapy on normal blood cells
    Emily Mitchell, My H. Pham, Anna Clay, Rashesh Sanghvi, Sandra Pietsch, Joanne I. Hsu, Hyunchul Jung, Aditi Vedi, Sarah Moody, Jingwei Wang et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  93. Therapy-selected clonal hematopoiesis and its role in myeloid neoplasms
    Jacob Jahn, Benjamin T. Diamond, Jeffrey Hsu, Skye Montoya, Tulasigeri M. Totiger, Ola Landgren, Francesco Maura, Justin Taylor · 2023 · Leukemia Research
  94. Clonal Hematopoiesis of Indeterminate Potential Influences Breast Cancer Outcomes in a Genotype-Specific Manner
    Sarah C. Reed, Chad R. Potts, Leo Y. Luo, Brad A. Davidson, Riley E. Bergman, Justin D.J. Kemp, Ethan K. Fox, Bryce A. Thomas, Lauren Ha, V.K. Arora et al. · 2025 · Clinical Cancer Research
  95. CHEK2 loss endows chemotherapy resistance to hematopoietic stem cells
    Jing Zhou, Tianyuan Hu, D. Li, Sanming Li, Minhua Li, Xiangguo E. Shi, Daisuke Nakada · 2026 · Leukemia
  96. Management of Peptide Receptor Radionuclide Therapy Toxicities in Neuroendocrine Neoplasm Patients
    Chirayu Mohindroo, Robert A. Ramirez · 2026 · Current Treatment Options in Oncology
  97. NGS-based Tissue-Blood TMB Comparison and Blood-TMB Monitoring in Stage-III Non-Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
    Luxi Ye, Xiao Chu, Jianjiao Ni, Li Chu, Xi Yang, Zhengfei Zhu · 2024 · Cancer Investigation
  98. Cancer Clones Revised
    Lucie Laplane · 2024 · Biological Theory
  99. Revolutionising Cardio-Oncology Care with Precision Genomics
    Jun Hua Chong, Charles T. H. Chuah, Caroline Guat Lay Lee · 2025 · International Journal of Molecular Sciences
  100. The systemic costs of hematopoietic stem cell aging
    Gayatri Puri, Roméo S. Blanc · 2025 · Development